Risperdal Lawsuits Menu

Receive a Free
Legal Consultation

  • This field is for validation purposes and should be left unchanged.

Have you or a loved one taken Risperdal and developed serious side effects from the drug? The pharmaceutical lawyers at Simmons Hanly Conroy are currently investigating claims that the prescription medication Risperdal has caused the development of male breasts, a condition called gynecomastia, in children and adolescents.

Risperdal has been linked to serious side effects and health complications among children and adolescents taking the drug. Young males may develop breasts and subsequently experience psychological trauma and the need for surgery to remove the breasts. Learn more about Risperdal side effects now.

If you or a loved one has experienced such complications from use of Risperdal, you may be eligible to file a lawsuit.

Background of Risperdal Lawsuits

A lawsuit filed by the U.S. Department of Justice states that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson and the maker of Risperdal, failed to disclose information on the serious side effects of Risperdal while marketing it for off-label uses in children.

According to the complaint, the pharmaceutical manufacturers “knew Risperdal posed certain health risks to children.” Regardless of this knowledge and repeated warnings from the U.S. Food and Drug Administration (FDA), the company continued to market the drug for off-label uses.

Risperdal was allegedly marketed before it was approved for adolescent use by the FDA. The drug was promoted to treat the following childhood disorders:

  • Attention deficit hyperactivity disorder
  • Oppositional defiant disorder
  • Obsessive-compulsive disorder
  • Autism

“J&J’s promotion of Risperdal for unapproved uses threatened the most vulnerable populations of our society – children, the elderly and those with developmental disabilities,” said U.S. Attorney for the Eastern District of Pennsylvania Zane Memeger in a statement on a recent settlement agreement with the company. “This historic settlement sends the message that drug manufacturers who place profits over patient care will face severe criminal and civil penalties.”

As a result of the lawsuit, Johnson & Johnson and Janssen Pharmaceuticals agreed to pay $2.2 billion to resolve the claim that the company falsely marketed and misbranded multiple prescription drugs, including Risperdal.

File a Risperdal Lawsuit

Shareholder Jayne Conroy co-leads the pharmaceutical attorneys.

Shareholder Jayne Conroy co-leads the pharmaceutical attorneys.

If you or someone you love has experienced negative side effects including the development of male breasts from use of Risperdal, the experienced Risperdal lawyers, led by named shareholders Paul Hanly and Jayne Conroy, at Simmons Hanly Conroy are here to help. We are currently investigating claims from people who have been harmed by Risperdal.

Contact us today to find out if you may be eligible to file a Risperdal lawsuit.

* Please note that recovery results vary per client. The recovery amounts in each case reflect the specific facts of that case. Further, recovery amounts in past cases are not a guarantee of future results.

Client Testimonials

I give thanks to the Simmons firm. I am so grateful. It seems like when something happens, like my roof or chimney leaking, we now have the funds.

View More Testimonials

- Elizabeth
Wife of Frederick, Client

167 queries. 0.622 seconds